A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers

Blood

Volumn 89, Issue 8, 1997, Pages 2880-2890

  Koch, Ute ^a   Korngold, Robert ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD4 ANTIGEN DERIVATIVE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030903113     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2880     Document Type: Article

References (52)

1. Poynton CH: T cell depletion in bone marrow transplantation. Bone Marrow Transplant 3:265, 1988
2. Marmont AA, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA, Herzig RH, Hong R, Masaoka T, Rimm AA, Ringden O, Speck B, Weiner RS, Bortin MM: T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120, 1991
3. Kernan NA: T-cell depletion for prevention of graft-versus-host disease, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Cambridge, MA, Blackwell Scientific, 1994, p 124
4. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P, Appelbaum FR, Clift R, Fefer A, Witherspoon RP, Kennedy MS, Sullivan KM, Flournoy N, Storb R, Thomas ED: Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66:664, 1985
5. Martin PJ, Hansen JA, Torok-Storb B, Durnam D, Przepiorka D, O'Quigley J, Sanders J, Sullivan KM, Witherspoon RP, Deeg HJ, Appelbaum FR, Stewart P, Weiden P, Doney K, Buckner CD, Clift R, Storb R, Thomas ED: Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant 3:445, 1988
6. Bosserman LD, Murray C, Takvorian T, Anderson KC, Freedman AS, Fitzsimmons J, Coral F, Nadler LM, Schlossman SF, Ritz J: Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients. Bone Marrow Transplant 4:239, 1989
7. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ: Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation 43:842, 1987
8. Bierer BE, Emerson SG, Antin J, Maziarz R, Rappeport JM, Smith BR, Burakoff SJ: Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation. Transplantation 46:835, 1988
9. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ: Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived anti-donor allocytotoxic T lymphocytes. Transplantation 43:842, 1987
10. Donohue J, Homge M, Kernan NA: Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor. Blood 82:1023, 1993
11. Wingard JR: Prevention and treatment of bacterial and fungal infections, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Cambridge, MA, Blackwell Scientific, 1994, p 363
12. McDonnell JM, Varnum JM, Mayo KH, Jameson BA: Rational design of a peptide analog of the L3T4 CDR3-like region. Immunomethods 1:33, 1992
13. Jameson BA, McDonnell JM, Marini JC, Korngold R: A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature 368:744, 1994
14. McDonnell JM, Blank KJ, Rao PE, Jameson BA: Direct involvement of the CDR3-like domain of CD4 in T helper cell activation. J Immunol 149:1626, 1992
15. Townsend RM, Briggs C, Marini JC, Murphy GF, Korngold R: Inhibitory effect of a CD4-CDR3 peptide analog on graft-vs-host disease across a MHC-haploidentical barrier. Blood 88:3038, 1996
16. Bruce J, Symington FW, McKearn TJ, Sprent J: A monoclonal antibody discriminating between subsets of T and B cells. J Immunol 127:2496, 1981
17. Dialynas DP, Wilde DB, Marrack P, Pierres A, Wall KA, Havran W, Otten G, Loken MR, Pierres M, Kappler J, Fitch FW: Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: Expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol Rev 74:29, 1983
18. Unkeless JC: Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 150:580, 1979
19. Vallera DA, Taylor PA, Sprent J, Blazar BR: The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice. Transplantation 57:249, 1994
20. Bailey DW, Usama B: A rapid method of grafting skin on tails of mice. Transplant Bull 7:424, 1960
21. Fujimori Y, Hara H, Nagai K: Effect of lymphokine-activated killer cell fraction on the development of human hematopoietic progenitor cells. Cancer Res 48:534, 1987
22. Spitzer G, Verma DS, Fisher R, Zander A, Vellekoop L, Litam J, McCredie KB, Dicke KA: The myeloid progenitor cell -Its value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 55:317, 1980
23. Storb R, Weiden PL: Transfusion problems associated with transplantation. Semin Hematol 18:163, 1981
24. Weyand CM, Goronzy J, Swarztrauber K, Fathman CG: Immunosuppression by anti-CD4 treatment in vivo. Persistence of secondary antiviral immune responses. Transplantation 47:1034, 1989
25. Chace JH, Cowdery JS, Field EH: Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J Immunol 152:405, 1994
26. Reiter C, Kakavand BB, Rieber EP, Schatten-Kirchner M, Riethmuller G, Kurger K: Treatment of rheumatoid arthritis with monoclonal CD4 antibody MT-151. Arthritis Rheum 34:525, 1991
27. Hafler DA, Ritz J, Schlossman SF, Weiner HL: Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses. J Immunol 141:131, 1988
28. Racadot E, Rumbach L, Bataillard M, Galmiche J, Henlin J-L, Truttmann M, Herve P, Wijdenes J: Treatment of multiple sclerosis with anti-CD4 monoclonal antibody: A preliminary report on B-F5 in 21 patients. J Autoimmunity 6:771, 1993
29. Lindsey JW, Hodgkinson S, Mehta R, Mitchell D, Enzmann D, Steinman L: Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis. Ann Neurol 36:183, 1994
30. Horneff G, Winkler T, Kalden JR, Emmrich F, Burmester GR: Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis. Clin Immunol Immunopath 59:89, 1991
31. + T cell responses in experimental allergic encephalomyelitis. J Immunol 157:3706, 1996
32. Langedijk JPM, Puijk WC, Van Hoorn WP, Meloen RH: Location of CD4 dimerization site explains critical role of CDR3-like region in HIV-1 infection and T-cell activation and implies a model for complex of coreceptor-MHC. J Biol Chem 268:16875, 1993
33. König R, Shen X, Germain RN: Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J Exp Med 182:779, 1995
34. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33, 1993
35. Sakihama T, Smolyar A, Reinherz EL: Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules. Immunol Today 16:581, 1995
36. Rudd CE, Trevillyan JM, Dasgupta JD, Wong LL, Schlossman SF: The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. Proc Natl Acad Sci USA 85:5190, 1988
37. Veillette A, Bolen JB, Bookman MA: Alterations in tyrosine protein phosphorylation induced by antibody-mediated cross-linking of the CD4 receptor of T lymphocytes. Mol Cell Biol 9:4441, 1989
38. lck with CD4 in antigen-specific signal transduction in T cells. Cell 64:511, 1991
39. Newell MK, Haughn LJ, Maroun C, Julius MH: Death of mature T cells by separate ligation of CD4 and T-cell receptor for antigen. Nature 347:286, 1990
40. Schwartz RH: A cell culture model for T lymphocyte clonal anergy. Science 248:1349, 1990
41. Mondino A, Jenkins MK: Surface proteins involved in T cell costimulation. J Leukoc Biol 55:805, 1994
42. + T cell subsets. Clin Exp Allergy 25:839, 1995
43. Hu Q, Davidson D, Schwartzberg PL, Macchiarini F, Lenardo MJ, Bluestone JA, Matis LA: Identification of Rlk, a novel protein tyrosine kinase with predominant expression in the T cell lineage. J Biol Chem 270:1928, 1995
44. Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM, Elfenbein GE, Gale RP, Gluckman E, Good RA, Rimm AA, Rozman C, Speck B, Bortin MM: Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 73:606, 1989
45. Kernan NA, Bordignon C, Heller G, Cunningham I, Castro-Malaspina H, Shank B, Flomenberg N, Burns J, Yang SY, Black P, Collins NH, O'Reilly RJ: Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 74:2227, 1989
46. O'Reilly RJ, Collins NH, Kernan N, Brochstein J, Dinsmore R, Kirkpatrick D, Siena S, Keever C, Jordan B, Shank B, Wolf L, Dupont B, Reisner Y: Transplantation of marrow-depleted T cells by soybean lectin agglutination and e-rosette depletion: Major histocompatibility complex-related graft resistance in leukemic transplant recipients. Transplant Proc 17:455, 1985
47. Beatty PG, Clift RA, Mickelson EM, Nisperos BB, Flournoy N, Martin PJ, Sanders JE, Stewart P, Buckner CD, Storb R, Thomas ED, Hansen JA: Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313:765, 1985
48. Bozdech MJ, Sondel PM, Trigg ME, Longo W, Kohler PC, Flynn B, Billing R, Anderson SA, Hank JA, Hong R: Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: Addition, of cytosine arabinoside to the pretransplant conditioning prevents rejection. Exp Hematol 13:1201, 1985
49. Barge AJ, Johnson G, Witherspoon R, Torok-Storb B: Antibody-mediated marrow failure after allogeneic bone marrow transplantation. Blood 74:1477, 1989
50. Bordignon C, Keever CA, Small TN, Flomenberg N, Dupont B, O'Reilly RJ, Kernan NA: Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms. Blood 74:2237, 1989
51. Sharabi Y, Sachs DH, Sykes M: T cell subsets resisting induction of mixed chimerism across various histocompatibility barriers, in Gergely J, Benczur M, Falus A, Füst GY, Madgyesi G, Petranyl GY, Rajnavölgyi E (eds): Progress in Immunology VIII. Heidelberg, Germany, Springer-Verlag, 1992, p 801
52. Friedman TM, Reddy AP, Wassell R, Jameson BA, Korngold R: Human CD4-CDR3 peptide analogs inhibit proliferation in human mixed lymphocyte reactions. J Biol Chem 271:22635, 1996